BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22628428)

  • 1. Roles of purinergic receptor P2Y, G protein-coupled 12 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Li D; Wang Y; Zhang L; Luo X; Li J; Chen X; Niu H; Wang K; Sun Y; Wang X; Yan Y; Chai W; Gartner TK; Liu J
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):e81-9. PubMed ID: 22628428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine diphosphate receptor P2Y12-mediated migration of host smooth muscle-like cells and leukocytes in the development of transplant arteriosclerosis.
    Harada K; Matsumoto Y; Umemura K
    Transplantation; 2011 Jul; 92(2):148-54. PubMed ID: 21629176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vessel wall, not platelet, P2Y12 potentiates early atherogenesis.
    West LE; Steiner T; Judge HM; Francis SE; Storey RF
    Cardiovasc Res; 2014 Jun; 102(3):429-35. PubMed ID: 24510394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
    Huo Y; Schober A; Forlow SB; Smith DF; Hyman MC; Jung S; Littman DR; Weber C; Ley K
    Nat Med; 2003 Jan; 9(1):61-7. PubMed ID: 12483207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2Y
    Niu X; Pi SL; Baral S; Xia YP; He QW; Li YN; Jin HJ; Li M; Wang MD; Mao L; Hu B
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):515-524. PubMed ID: 28062501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of platelet P-selectin in the response to arterial injury in apolipoprotein-E-deficient mice.
    Manka D; Forlow SB; Sanders JM; Hurwitz D; Bennett DK; Green SA; Ley K; Sarembock IJ
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1124-9. PubMed ID: 15072990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sLRP1 (Soluble Low-Density Lipoprotein Receptor-Related Protein 1): A Novel Biomarker for P2Y12 (P2Y Purinoceptor 12) Receptor Expression in Atherosclerotic Plaques.
    Chen J; Pi S; Yu C; Shi H; Liu Y; Guo X; Zhou L; Li Y; He H; Xia Y; Mao L; Hu B
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):e166-e179. PubMed ID: 32349534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice.
    Raj T; Kanellakis P; Pomilio G; Jennings G; Bobik A; Agrotis A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1845-51. PubMed ID: 16709940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
    Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF
    Circulation; 2006 Jan; 113(1):108-17. PubMed ID: 16380543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
    Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
    J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of platelet activation by P2Y12 receptor in the development of transplant arteriosclerosis in mice.
    Yashiro K; Matsumoto Y; Ihara H; Suzuki Y; Kondo K; Urano T; Umemura K
    Transplantation; 2009 Mar; 87(5):660-7. PubMed ID: 19295309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
    Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
    Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
    Hernández-Vargas P; Ortiz-Muñoz G; López-Franco O; Suzuki Y; Gallego-Delgado J; Sanjuán G; Lázaro A; López-Parra V; Ortega L; Egido J; Gómez-Guerrero C
    Circ Res; 2006 Nov; 99(11):1188-96. PubMed ID: 17053192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis.
    Evans DJ; Jackman LE; Chamberlain J; Crosdale DJ; Judge HM; Jetha K; Norman KE; Francis SE; Storey RF
    Circulation; 2009 Jan; 119(1):116-22. PubMed ID: 19103996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.
    Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.